Skip to main content

ADVERTISEMENT

radiation therapy

Research in Review
08/09/2017
JCP Editors
A recent study combined and analyzed data from three trials regarding the use of first-line chemotherapy plus selective internal radiotherapy in patients with colorectal cancer and liver metastases, published in The...
A recent study combined and analyzed data from three trials regarding the use of first-line chemotherapy plus selective internal radiotherapy in patients with colorectal cancer and liver metastases, published in The...
A...
08/09/2017
Journal of Clinical Pathways
Research in Review
08/01/2017
JCP Editors
A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment, according to recent research published in Cancer (online July 31, 2017;...
A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment, according to recent research published in Cancer (online July 31, 2017;...
A...
08/01/2017
Journal of Clinical Pathways
Research in Review
07/19/2017
JCP Editors
Stereotactic body radiation therapy (SBRT) is a safe treatment for patients aged 80 years or older with early-stage lung cancer, according to a recent study published in the International Journal of Radiation...
Stereotactic body radiation therapy (SBRT) is a safe treatment for patients aged 80 years or older with early-stage lung cancer, according to a recent study published in the International Journal of Radiation...
...
07/19/2017
Journal of Clinical Pathways
Research in Review
06/28/2017
JCP Editors
A new prognostic model for lung cancer with brain metastases uses histology, mutations, number of metastases, performance status, and age to accurately predict survival outcomes in patients, according to research...
A new prognostic model for lung cancer with brain metastases uses histology, mutations, number of metastases, performance status, and age to accurately predict survival outcomes in patients, according to research...
A new...
06/28/2017
Journal of Clinical Pathways
Research in Review
06/01/2017
JCP Editors
Patients with head and neck cancer who do not receive supportive services are more likely to miss radiation therapy appointments and lose weight during treatment, according to research presented at the 2017 ASCO...
Patients with head and neck cancer who do not receive supportive services are more likely to miss radiation therapy appointments and lose weight during treatment, according to research presented at the 2017 ASCO...
...
06/01/2017
Journal of Clinical Pathways
Research in Review
05/19/2017
JCP Editors
Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...
Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...
...
05/19/2017
Journal of Clinical Pathways
Research in Review
05/16/2017
JCP Editors
PD-L1 expression may be a biomarker of local failure in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma following radiotherapy, according to research published in Clinical Cancer Research...
PD-L1 expression may be a biomarker of local failure in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma following radiotherapy, according to research published in Clinical Cancer Research...
PD-L1...
05/16/2017
Journal of Clinical Pathways
Research in Review
05/09/2017
JCP Editors
Patients with rectal cancer who undergo first-line chemotherapy and radiation have lower risk of recurrence and higher rates of survival regardless of whether they choose to have surgery, according to a study...
Patients with rectal cancer who undergo first-line chemotherapy and radiation have lower risk of recurrence and higher rates of survival regardless of whether they choose to have surgery, according to a study...
...
05/09/2017
Journal of Clinical Pathways
Research in Review
05/08/2017
JCP Editors
A radiation schedule half the standard course is as safe and effective for patients with breast cancer following a mastectomy, according to a study published in the Journal of Clinical Oncology (published...
A radiation schedule half the standard course is as safe and effective for patients with breast cancer following a mastectomy, according to a study published in the Journal of Clinical Oncology (published...
A...
05/08/2017
Journal of Clinical Pathways
Interview
03/23/2017
JCP Editors
Journal of Clinical Pathways spoke with Peter Martin, MD, Lymphoma Service Chief, Weill Cornell Medicine and New York-Presbyterian, about the role of targeted therapies and clinical pathways in...
Journal of Clinical Pathways spoke with Peter Martin, MD, Lymphoma Service Chief, Weill Cornell Medicine and New York-Presbyterian, about the role of targeted therapies and clinical pathways in...
...
03/23/2017
Journal of Clinical Pathways